How much does tirzepatide cost, with and without insurance?

Tirzepatide tends to be the more expensive GLP-1/GIP molecule across the board — brand and compounded alike — and the reasons why are worth understanding before you compare a quote. Here's how the pricing actually shakes out.

Two brands, one molecule, different labels

Zepbound (tirzepatide for chronic weight management) and Mounjaro (tirzepatide for type 2 diabetes) are the same active drug sold under two FDA-approved brand names for two different indications⁵. Like semaglutide's two brands, the list price sits well above what most patients actually pay once insurance, manufacturer savings programs, or compounding enter the picture — a quoted list price alone tells you very little about your real cost.

Why tirzepatide usually costs more than semaglutide

Across cost-effectiveness modeling, tirzepatide is consistently priced and modeled at a premium relative to semaglutide, reflecting both its list price and, in some analyses, its larger average weight-loss effect per trial data¹⁴. A short-term US payer-perspective analysis comparing tirzepatide against semaglutide and liraglutide found tirzepatide costlier on a monthly basis even as it modeled greater weight loss per dollar over time in some scenarios². In the cash-pay compounded market the same pattern generally holds — tirzepatide compounding is more complex than semaglutide's, and providers price it accordingly. Our tirzepatide-only price and footprint board tracks who's actually cheapest on this molecule specifically, since the general cheapest GLP-1 board mixes both molecules together.

What insurance and coverage actually determine

As with semaglutide, whether your plan covers tirzepatide for weight loss (versus diabetes) is the largest single factor in your real cost, and it is not guaranteed — plan design varies by employer, and government coverage for anti-obesity medications remains an unsettled policy question with real fiscal stakes attached to any expansion³. When coverage exists, expect prior authorization requirements tied to BMI thresholds and documented weight-management attempts; we cover exactly how that process works in our insurance coverage guide. Manufacturer coupons can meaningfully lower a covered patient's copay but typically exclude patients on government insurance.

The compounded option

Compounded tirzepatide, made by a licensed 503A or 503B pharmacy rather than sold as an FDA-approved product, is the reason the cash-pay market exists at anything close to an affordable monthly number. Pricing is set by the provider and its pharmacy partner, not a manufacturer, and it moves with supply and regulatory posture the same way compounded semaglutide does — see GLP-1 shortages and supply for why that matters right now. If you're weighing whether the compounded route is worth it against the brand specifically, Mounjaro vs Zepbound vs compounded tirzepatide lays out what's actually different beyond price, and is compounded semaglutide legit? covers the same vetting checklist that applies to compounded tirzepatide pharmacies too.

Reading a tirzepatide quote correctly

The same rules that apply to any GLP-1 quote apply here, doubled: find the price at your likely maintenance dose (tirzepatide's schedule tops out higher than semaglutide's, at 15 mg for most patients who titrate all the way up), not the starting 2.5 mg dose; add in any membership or consultation fee; and ask whether the price is locked or subject to step-ups. The mechanics behind why a quoted price moves over time are covered fully in why GLP-1 prices move, and our 5-minute provider checklist covers what else to verify beyond the number. Every provider's current pricing is tracked in our provider briefs; figures reflect each provider's published pricing at our last review, not a fixed guarantee. This is market context, not medical or financial advice.